JHL Capital Group’s Surgery Partners SGRY Stock Holding History

JHL Capital Group’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-100,000	Closed	-$2.27M	–	14
2017 Q2	$2.27M	Buy	+100,000	New	+$2.06M	0.45%	14

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JHL Capital Group's SGRY Position: Q3 2017 in Review

JHL Capital Group sold out of Surgery Partners (SGRY) in Q3 2017, closing a stake of 100,000 shares — an estimated $2.27M sold.

JHL Capital Group first reported a position in SGRY in Q2 2017 and held it in 1 quarter. The position peaked at $2.27M in Q2 2017. 90 funds tracked by Wall St. Rank hold SGRY as of Q3 2017.

JHL Capital Group reported no remaining Surgery Partners position as of Q3 2017 after selling out during the quarter.
JHL Capital Group sold 100,000 Surgery Partners shares in Q3 2017, an estimated $2.27M.
JHL Capital Group first reported a position in Surgery Partners in Q2 2017 and held it in 1 quarter.
JHL Capital Group's Surgery Partners position peaked at $2.27M in Q2 2017.
90 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2017.

Based on JHL Capital Group's 13F filing for Q3 2017, filed 14 Nov 2017.